Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In |
Active Substance | Strength | Form |
---|---|---|
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf | International |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In | Q2 2024 |